GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 281 filers reported holding GLOBUS MED INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703,044 | +2367.7% | 14,160 | +2715.1% | 0.02% | +1800.0% |
| Q1 2023 | $28,490 | +59.8% | 503 | +109.6% | 0.00% | 0.0% |
| Q4 2022 | $17,825 | +791.2% | 240 | +650.0% | 0.00% | – |
| Q2 2021 | $2,000 | -95.1% | 32 | -94.9% | 0.00% | -100.0% |
| Q4 2020 | $41,000 | -60.6% | 628 | -69.9% | 0.00% | -60.0% |
| Q3 2020 | $104,000 | +258.6% | 2,085 | +215.0% | 0.01% | +150.0% |
| Q1 2020 | $29,000 | +7.4% | 662 | +40.9% | 0.00% | +100.0% |
| Q4 2019 | $27,000 | -20.6% | 470 | -40.7% | 0.00% | -50.0% |
| Q3 2019 | $34,000 | 0.0% | 792 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $34,000 | +580.0% | 792 | +620.0% | 0.00% | – |
| Q1 2019 | $5,000 | -28.6% | 110 | -29.0% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | -91.1% | 155 | -89.7% | 0.00% | -83.3% |
| Q2 2018 | $79,000 | +3850.0% | 1,501 | +2963.3% | 0.01% | – |
| Q1 2018 | $2,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |